Login
Search
Search
0 Dates
2026
2025
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
CPC 2025
CPC 2026
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Real-World Outcomes of Transvenous Lead Extraction using PISA technique: A 10-Year in Portugal Experience
Session:
Sessão de Comunicações Orais 03 – Intervenções avançadas na doença vascular pulmonar e em complicações de dispositivos
Speaker:
Leonor Magalhães
Congress:
CPC 2026
Topic:
H. Interventional Cardiology and Cardiovascular Surgery
Theme:
09. Device Therapy
Subtheme:
09.5 Device Complications and Lead Extraction
Session Type:
Comunicações Orais
FP Number:
---
Authors:
Leonor Magalhães; Margarida G. Figueiredo; Sofia Jacinto; Helder Santos; Pedro Silva Cunha; Guilherme Portugal; Pedro Osório; Ana Lousinha; Pedro Coelho; Rui Cruz Ferreira; Bruno Valente; Mário Martins Oliveira
Abstract
<p style="text-align:justify"><span style="font-size:12pt"><span style="font-family:Aptos,sans-serif"><strong><span style="font-family:"Calibri",sans-serif">Introduction: </span></strong><span style="font-family:"Calibri",sans-serif"> The increasing use of cardiovascular implantable electronic devices (CIEDs) has driven a growing need for safe and effective transvenous lead extraction (TLE). We report a comprehensive 10-year experience from a single high-volume center using the PISA technique (PT), a rotational sheath–based approach for TLE. </span></span></span></p> <p style="text-align:justify"><span style="font-size:12pt"><span style="font-family:Aptos,sans-serif"><strong><span style="font-family:"Calibri",sans-serif">Methods: </span></strong><span style="font-family:"Calibri",sans-serif">Retrospective study including all patients undergoing TLE at a national referral center between February 2013 and December 2024. Clinical and radiological success as defined by HRS/EHRA criteria, complications, and mortality were analyzed.</span></span></span></p> <p style="text-align:justify"><span style="font-size:12pt"><span style="font-family:Aptos,sans-serif"><strong><span style="font-family:"Calibri",sans-serif">Results: </span></strong><span style="font-family:"Calibri",sans-serif">A total of 530 leads were extracted from 283 patients (P) (median age 73 years [IQR 59–81], 72.4% male) [Table 1]. Lead dwell time was prolonged, with a median duration of 96 months (48–144). Pacemakers were most frequently extracted (72.2%), followed by implantable cardioverter-defibrillators (14.9%) and cardiac resynchronization therapy systems (12.8%) [Table 2].<br /> Although infection was the leading indication for extraction (74.6%); 25.4% of the procedures were due to non-infectious causes (25.4%), mainly for lead dysfunction. [Table 3]<br /> Clinical and radiological success were extremely high (95.7% and 97.2%). Major and minor (mainly due to minor pocket hemorrhage) procedure-related complications occurred in 8P and 16P, respectively. Device reimplantation was performed in 168P (68.2%), with 188 occurring during the index hospitalization. No intraprocedural deaths occur and only 4.5% all causes in-hospital mortality [Table 4]. </span></span></span></p> <p style="text-align:justify"><span style="font-size:12pt"><span style="font-family:Aptos,sans-serif"><span style="font-family:"Calibri",sans-serif">Lead dwell time showed a strong association with extraction failure (p>0.001), but not complications or mortality (p=0.102 and p=0.078). Only the TLE of a CRT system was significantly associated with major complications (p=0.016); but due to low frequency events, no complications predictors were found. No baseline clinical, procedural or device-related variable was significantly associated with clinical failure. </span></span></span></p> <p style="text-align:justify"><span style="font-size:12pt"><span style="font-family:Aptos,sans-serif"><span style="font-family:"Calibri",sans-serif">Older age and chronic kidney disease independently conferred a higher risk of all-cause mortality (OR 1.033 per year, 95% CI 1.010–1.057; p=0.005 and OR 2.25, 95% CI 1.23–4.09; p=0.008, respectively).</span></span></span></p> <p style="text-align:justify"><span style="font-size:12pt"><span style="font-family:Aptos,sans-serif"><strong><span style="font-family:"Calibri",sans-serif">Conclusion</span></strong><span style="font-family:"Calibri",sans-serif">: Transvenous lead extraction using the PISA technique is a highly effective approach, with low complication and mortality rates in patients with CIEDs. These findings support the broad applicability and reproducibility safety of this extraction strategy across heterogeneous clinical and device profiles.</span></span></span></p>
Our mission: To reduce the burden of cardiovascular disease
Visit our site